Qualigen Therapeutics's total assets for Q1 2025 were $2.85M, a decrease of -39.24% from the previous quarter. QLGN total liabilities were $2.81M for the fiscal quarter, a 40.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.